Hormone

Researchers have developed a novel technique that combines two diabetes drugs into a single injection. Previously these compounds required separate injections, creating a barrier for treatment that led to few diabetics embracing the novel therapy.

A compelling new study, led by scientists from Washington University School of Medicine in St. Louis, has found a novel gene therapy can prevent obesity and build muscle without the need for additional exercise, in mice being fed a high-fat diet.

Four years after it was announced, the results of a controversial clinical trial have been published, finding a testosterone-reducing drug, originally developed for prostate cancer, lowered sexual interest in children for men with pedophilic disorder.

A new study led by researchers from the Stanford School of Medicine suggests low levels of a hormone called vasopressin, measured in three-month-old babies, may serve as a predictive biomarker of autism spectrum disorder (ASD) in later childhood.

A study has found an infusion of the naturally occurring hormone called kisspeptin can enhance brain activity related to sexual attraction in response to visual and odor cues. This suggests the hormone may be an effective treatment for low libido.

In the largest study ever conducted investigating disease risk and genetic sex hormone levels researchers have found naturally high testosterone levels can confer different effects between men and women, particularly in relation to type 2 diabetes.

New research is offering compelling evidence to suggest levels of a steroid hormone called allopregnanolone can affect fetal brain development, and when disrupted can result in cerebral abnormalities and increases in autism risk.

Ghrelin, the “hunger hormone”, has been associated with brain lesions thought to play a role in cognitive decline seen in Alzheimer's.

A study suggests the drugs used to initially treat breast cancer may be triggering some cancer cells to enter a dormant state.

A new study has discovered a mechanism explaining how obesity and high-fat diets can disrupt the appetite-suppressing signals from the brain and lead to overeating. The fascinating research revealed a hormone in the gut, triggered by high-fat meals, actually induces the body to keep eating.

A new slow-release hormone treatment is being touted as an alternative to gastric bypass surgery in obese patients suffering from type 2 diabetes. The novel therapy delivers three appetite-regulating hormones via a subcutaneous pump, resulting in weight loss and improved blood glucose levels.

Two studies are suggesting modulating activity of the hormone vasopressin may help treat the social impairments associated with autism. The two trials use different approaches but some experts are suggesting it is too early to conclude these hormones would be beneficial to all autistic subjects.